# India Gamma Knife Market > India Gamma Knife Market Research Report: Size, Share, Trend Analysis By Disease Indication (Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, Others) and By Anatomy (Head, Neck, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.76% - **2024:** $ 27.88 Million - **2025:** $ 29.76 Million - **2035:** $ 57.28 Million - **Key Players:** Elekta AB (SE), Accuray Incorporated (US), Varian Medical Systems (US), Brainlab AG (DE), MediTech (US), Shenzhen Huikang Medical Technology Co., Ltd. (CN), Nico Corporation (US), Stereotactic Radiosurgery (US) **Report ID:** MRFR/HC/50658-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-gamma-knife-market-52416 --- ## Market Summary ## **India Gamma Knife Market Overview** As per MRFR analysis, the India Gamma Knife Market Size was estimated at 26.62 (USD Million) in 2024.The India Gamma Knife Market Industry is expected to grow from 36.8(USD Million) in 2025 to 69.8 (USD Million) by 2035. The India Gamma Knife Market CAGR (growth rate) is expected to be around 5.992% during the forecast period (2025 - 2035) **Key India Gamma Knife Market Trends Highlighted** The India Gamma Knife Market is experiencing notable trends driven by the increasing incidence of neurological disorders such as brain tumors and other cranial conditions. As healthcare facilities in India enhance their capabilities, there is a growing adoption of advanced technologies like Gamma Knife radiosurgery. This non-invasive treatment method is gaining popularity due to its precision and effectiveness, reducing the need for traditional surgeries that often involve longer recovery times. Furthermore, the awareness of radiation therapy's benefits among both medical professionals and patients is on the rise, leading to higher demand for such innovative solutions. The opportunities to be explored in the India Gamma Knife Market include expanding access to treatment in tier-2 and tier-3 cities. As healthcare infrastructure improves and more facilities invest in advanced technologies, a larger patient population can receive timely and effective treatments. Collaborations between public and private sectors could facilitate this expansion, ensuring that more patients benefit from Gamma Knife procedures. Moreover, the potential for integrating Gamma Knife technology with artificial intelligence for enhanced treatment planning presents a significant growth avenue.  In recent times, the trend of increasing government support for healthcare initiatives in India is also influential.Programs aimed at improving cancer care and funding for advanced equipment are encouraging hospitals to adopt cutting-edge technologies like Gamma Knife. The rise of medical tourism in India, with international patients seeking advanced treatment options, further supports the expansion of this market. Overall, the evolving landscape of healthcare in India is fostering a conducive environment for the growth of the Gamma Knife Market, ultimately benefiting patient outcomes and healthcare efficiency. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **India Gamma Knife Market Drivers** **Increasing Incidence of Cancer** India has seen a remarkable surge in cancer cases, with an estimated rise of over 15% in the last decade. According to the National Cancer Registry Programme of India, the number of new cancer cases reported annually now exceeds 1.3 million. This alarming statistic underscores the growing need for advanced treatment methods such as Gamma Knife surgery, which is specifically designed for treating brain tumors and other cancers affecting the brain.  Established organizations like the Tata Memorial Centre are continuously enhancing cancer treatment facilities, thereby cementing the necessity for state-of-the-art technologies like those found in the India Gamma Knife Market Industry.An expanding patient population is increasing the market, fueling the demand for effective cancer management solutions. **Technological Advancements in Gamma Knife Treatment** Ongoing technological advancements and innovations in Gamma Knife systems have played a pivotal role in promoting their adoption within the healthcare sector. Newer models offer enhanced precision and safety, making procedures quicker and less invasive. A report from the Medical Council of India highlights that improved treatment technologies have contributed to an increase in successful patient outcomes by up to 30%.  Major players such as Elekta have invested in Research and Development to enhance their Gamma Knife models, solidifying their presence in the India Gamma Knife Market Industry.This technological evolution directly motivates healthcare providers to adopt these solutions, driving market growth considerably. **Government Initiatives to Improve Healthcare Infrastructure** The Government of India has taken significant steps to enhance healthcare infrastructure, especially concerning cancer treatment facilities. Initiatives such as the National Health Mission have allocated substantial budgets to improve public healthcare services across urban and rural areas. According to government data, healthcare spending in India has increased by over 12% in recent years, fostering better access to specialized treatment options like Gamma Knife surgery.This policy direction encourages hospitals and clinics to integrate advanced treatment technologies into their services, thereby amplifying the potential for growth within the India Gamma Knife Market Industry. **India Gamma Knife Market Segment Insights** **Gamma Knife Market Disease Indication Insights** The Disease Indication segment of the India Gamma Knife Market displays significant growth potential, attributed to the increasing prevalence of neurological disorders and the rising demand for minimally invasive treatment options. With advancements in medical technology and enhanced patient awareness, conditions such as Brain Metastasis, Cancer, Arteriovenous Malformation, and Trigeminal Neuralgia are emerging as key focus areas within the market. Brain Metastasis remains a leading concern due to the growing incidence of systemic malignancies, pushing healthcare systems to adopt Gamma Knife radiosurgery as an effective, non-invasive approach for brain lesions. Cancer treatment has seen a notable integration of Gamma Knife procedures, promoting better patient outcomes and reduced recovery times, which is pivotal in India's expanding healthcare landscape. Furthermore, Arteriovenous Malformation cases continue to rise, necessitating precision-targeted therapies to minimize risks associated with traditional surgical methods. Trigeminal Neuralgia, a debilitating condition, is also addressed effectively through Gamma Knife technology, providing relief to countless patients suffering from chronic pain without the need for invasive procedures. The distribution of these conditions across India's diverse population ultimately drives the demand for cutting-edge treatment modalities, influencing healthcare policies and investment in infrastructure dedicated to neurosurgical advancements. By catering to a range of conditions, the segmentation within the India Gamma Knife Market offers an array of opportunities for growth, as it aligns with the nation’s focus on enhancing healthcare accessibility and quality while addressing the unique medical needs of the populace.  The overall market data suggest a steady increase in the utilization of Gamma Knife technology, supported by government initiatives aimed at improving radiology practices and increasing awareness regarding non-invasive treatment options. The amalgamation of these factors creates a favorable environment for sustained growth in the Disease Indication segment within the India Gamma Knife Market, with a clear trajectory towards improved technology adoption and treatment efficacy in addressing complex brain conditions. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Gamma Knife Market Anatomy Insights** The Anatomy segment of the India Gamma Knife Market focuses primarily on areas such as the Head, Neck, and other regions, reflecting a crucial aspect of this advanced therapeutic practice. The Head segment is paramount due to the prevalence of neurological disorders, attracting considerable attention and investment in treatment methodologies. This is particularly evident as India faces a rising trend in brain-related health issues, necessitating effective treatment options. The Neck segment addresses a variety of conditions like tumors and vascular malformations, highlighting its significance in improving patient outcomes. Moreover, the 'Others' category encompasses different anatomical regions, providing a wider scope in applications and treatment approaches. As the India Gamma Knife Market evolves, the incorporation of technological advancements in precision medicine continues to drive growth across these segments. A focus on enhancing awareness and accessibility to Gamma Knife procedures can further strengthen the overall market landscape, reflecting a dedication to improving healthcare standards within the country. Understanding this segmentation is critical for stakeholders seeking to navigate the evolving dynamics of the India Gamma Knife Market effectively. **India Gamma Knife Market Key Players and Competitive Insights** The India Gamma Knife Market has been experiencing significant growth, characterized by advancements in technology and an increasing focus on precise and effective treatment options for patients with neurological conditions. This market, which specializes in non-invasive treatments primarily for brain tumors, arteriovenous malformations, and other critical neurological disorders, has witnessed heightened competition among various healthcare providers. Factors contributing to this competitive landscape include the rising awareness of gamma knife radiosurgery, investments in healthcare infrastructure, and collaborations between healthcare facilities and technology providers.  As hospitals and clinics enhance their services to cater to patient needs, the industry dynamics are continually evolving, offering a comprehensive view of the competitive insights within the India Gamma Knife Market.Zydus Hospitals has positioned itself as a prominent player in the India Gamma Knife Market due to its commitment to cutting-edge technology and quality patient care. The hospital emphasizes its advanced healthcare infrastructure and state-of-the-art gamma knife facilities, making it a preferable choice for patients seeking non-invasive treatment. Zydus Hospitals prides itself on its multidisciplinary approach, where a team of experienced professionals collaborates in providing tailored treatment plans for patients undergoing gamma knife procedures.  The institution’s robust operational capabilities, coupled with its strong brand reputation, contribute to its competitive standing in the market. Zydus Hospitals actively promotes research and clinical trials related to gamma knife applications, underscoring its dedication to remaining at the forefront of advances in this specialized field.Max Healthcare also holds a significant position in the India Gamma Knife Market, focusing on delivering comprehensive cancer care services, particularly for neurological conditions treated with gamma knife radiosurgery. The company is known for its advanced medical technology and skilled specialists who ensure high standards of patient care.  Max Healthcare has established a strong presence in urban centers across India, making it accessible to a larger patient population. The company's strengths lie not only in its cutting-edge treatment facilities but also in its focus on patient-centered care and multidisciplinary collaboration among healthcare professionals. Max Healthcare has engaged in strategic alliances and partnerships that enhance its service offerings, including potential collaborations with global healthcare innovators. By continuing to invest in technology and expanding its capabilities, Max Healthcare is well-positioned to address the growing demand for gamma knife treatments in the Indian healthcare landscape. **Key Companies in the India Gamma Knife Market Include** **India Gamma Knife Market Industry Developments** India's Gamma Knife Market has seen significant developments recently, enhancing its landscape. Zydus Hospitals and Max Healthcare have expanded their services to include advanced stereotactic radiosurgery, improving patient access to cutting-edge treatment options. HCG Oncology and Sunrise Oncology are also enhancing their capabilities, ensuring better treatment of neurological disorders.  June 2023 highlighted a notable collaboration between Narayana Health and Varian Medical Systems to develop advanced cancer treatment protocols incorporating Gamma Knife technology. In terms of mergers and acquisitions, Elekta announced in August 2023 its agreement to acquire a stake in a leading neurosurgery center, enhancing its presence in India's burgeoning market.  The Indian Gamma Knife market is projected to grow substantially, with a focus on increased technological investment. The overall market valuation is on the rise, reflecting the enhanced healthcare infrastructure and the growing need for non-invasive cancer treatment options in India. Fortis Healthcare and Apollo Hospitals are also upgrading their facilities, which contributes to competitive advancements in the sector. The concerted effort by these major players reflects a commitment to embracing innovative technologies in neurosurgical procedures, shaping a more robust healthcare landscape in India. **India Gamma Knife Market Segmentation Insights** ## Market Drivers ### Government Initiatives and Funding Government initiatives aimed at enhancing healthcare infrastructure in India are playing a crucial role in the growth of the gamma knife market. The Indian government has been actively promoting advanced medical technologies through various funding programs and public-private partnerships. These initiatives are designed to improve access to cutting-edge treatments, including gamma knife radiosurgery, particularly in underserved regions. With an increasing focus on reducing the burden of neurological disorders, the government is likely to allocate more resources towards the development of specialized treatment centers equipped with gamma knife technology. This support could potentially lead to a market growth of around 20% over the next five years, as more facilities adopt this innovative treatment modality. ### Increase in Healthcare Expenditure In India, the increase in healthcare expenditure is positively impacting the gamma knife market. As the government and private sectors allocate more funds towards healthcare, there is a corresponding rise in investments in advanced medical technologies, including gamma knife systems. This trend is indicative of a broader commitment to improving healthcare outcomes and expanding access to innovative treatments. With healthcare expenditure projected to grow by approximately 12% annually, the gamma knife market is likely to benefit from enhanced funding for new equipment and training for medical professionals. This financial support could facilitate the establishment of more treatment centers, thereby increasing the availability of gamma knife procedures across the country. ### Technological Innovations in Treatment Technological innovations in the gamma knife market are driving advancements in treatment efficacy and patient outcomes. Continuous improvements in imaging techniques and treatment planning software are enhancing the precision of gamma knife procedures. These innovations allow for better targeting of tumors and improved treatment planning, which can lead to higher success rates and reduced side effects. As hospitals and clinics in India adopt these advanced technologies, the gamma knife market is expected to witness substantial growth. The integration of artificial intelligence and machine learning into treatment protocols may further optimize patient care, potentially increasing market growth by 25% over the next few years. This trend underscores the importance of staying at the forefront of technological advancements in the healthcare sector. ### Growing Awareness and Patient Education Awareness regarding the benefits of gamma knife treatment is steadily increasing among patients and healthcare professionals in India. Educational campaigns and outreach programs are being implemented to inform the public about the advantages of this technology, particularly in treating complex neurological conditions. As patients become more informed about their treatment options, there is a growing inclination towards seeking gamma knife procedures. This shift in patient preference is expected to contribute to a significant rise in the gamma knife market, with projections indicating a potential increase of 18% in market size by 2026. Enhanced patient education is likely to foster a more informed patient base, which could lead to higher demand for gamma knife services. ### Rising Demand for Non-Invasive Treatments In India, the gamma knife market is experiencing a notable increase in demand for non-invasive treatment options. Patients and healthcare providers are increasingly favoring procedures that minimize recovery time and reduce the risk of complications. This trend is particularly evident in the treatment of brain tumors and vascular malformations, where traditional surgical methods may pose higher risks. The non-invasive nature of gamma knife radiosurgery allows for precise targeting of tumors while sparing surrounding healthy tissue. As awareness of these benefits grows, the market is projected to expand significantly, with estimates suggesting a growth rate of approximately 15% annually over the next few years. This rising demand is likely to drive investments in gamma knife technology and facilities across India, further solidifying its position in the healthcare landscape. ## Future Outlook The [Gamma Knife Market](https://www.marketresearchfuture.com/reports/gamma-knife-market-19189) in India is projected to grow at a 6.76% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare investments, and rising demand for non-invasive treatments. **New opportunities:** - Expansion of telemedicine services for remote consultations and follow-ups. - Development of cost-effective gamma knife models for smaller healthcare facilities. - Partnerships with research institutions for innovative treatment protocols and clinical trials. By 2035, the gamma knife market is expected to achieve substantial growth and enhanced accessibility. ## Segment Insights ### By Disease Indication: Brain Metastasis (Largest) vs. Cancer (Fastest-Growing) In the India gamma knife market, market share distribution among the disease indications reveals Brain Metastasis as the largest segment, accounting for a significant portion due to its high prevalence. Following this, Cancer represents a considerable share as well, with segments such as Arteriovenous Malformation and Trigeminal Neuralgia holding smaller portions. The Others category also contributes, but to a lesser extent, indicating diverse treatment needs across these indications. Growth trends within the segment showcase Cancer as the fastest-growing indication, driven by increasing cancer incidences and advancements in gamma knife technology. The demand for non-invasive treatment options for Brain Metastasis persists due to a growing elderly population. Together, these factors fuel the need for gamma knife procedures, highlighting a robust market trajectory fueled by innovation and rising awareness across India. Brain Metastasis (Dominant) vs. Cancer (Emerging) In the context of the India gamma knife market, Brain Metastasis remains the dominant disease indication, capitalizing on the increasing number of patients requiring targeted therapy. This segment benefits from heightened awareness and advancements in medical technology that enhance treatment precision. On the other hand, Cancer is emerging as a significant player, reflecting the rising incidence of various cancer forms and the push for effective non-invasive treatment options. Both sections underscore a shift towards innovative treatment methodologies, with Brain Metastasis leading the charge while Cancer experiences rapid growth due to evolving healthcare needs and improved treatment technologies. ### By Anatomy: Head (Largest) vs. Neck (Fastest-Growing) In the India gamma knife market, the 'Head' segment holds the largest share, owing to the high prevalence of brain-related conditions that necessitate advanced treatment options like gamma knife surgery. The 'Neck' segment, while smaller, is rapidly gaining traction as awareness of treatments for cervical cancer and other neck conditions increases. This distribution reflects a strong demand for targeted therapies across varying anatomical regions. Growth trends indicate that the demand for gamma knife treatments is surging, particularly in the 'Neck' segment, which is considered the fastest-growing area. Factors such as increasing incidences of head and neck cancers, coupled with technological advancements in gamma knife surgery, are propelling this growth. The development of more precise, less invasive methods affects patient preferences positively and drives market expansion. Head (Dominant) vs. Neck (Emerging) The 'Head' segment in the India gamma knife market is dominant due to its extensive application in treating a range of brain disorders, including malignant tumors and vascular malformations. This segment benefits from established clinical protocols and a higher volume of procedures performed annually, ensuring its market leadership. In contrast, the 'Neck' segment is emerging, fueled by rising awareness and the increasing prevalence of neck-related diseases. Innovations in gamma knife technologies are making treatments more efficient and accessible, gradually enhancing the neck's market position. As healthcare providers continue to invest in training and technology, the neck segment's growth is expected to accelerate significantly in the coming years. ## Competitive Benchmarking The gamma knife market in India is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for non-invasive treatment options. Key players such as Elekta AB (SE), Accuray Incorporated (US), and Varian Medical Systems (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Elekta AB (SE) focuses on innovation, particularly in enhancing the precision of its gamma knife systems, which positions it favorably against competitors. Meanwhile, Accuray Incorporated (US) emphasizes partnerships with local healthcare providers to expand its reach, while Varian Medical Systems (US) is investing heavily in digital transformation initiatives to streamline operations and improve patient outcomes. Collectively, these strategies contribute to a competitive environment that is increasingly centered around technological superiority and strategic collaborations.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of India's diverse healthcare landscape. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they set benchmarks for quality and innovation that smaller firms strive to meet. In October Elekta AB (SE) announced the launch of its latest gamma knife model, which incorporates advanced imaging technology to enhance treatment accuracy. This strategic move is likely to solidify Elekta's position as a leader in the market, as it addresses the growing demand for precision in stereotactic radiosurgery. The introduction of this model not only showcases Elekta's commitment to innovation but also reflects a broader trend towards integrating cutting-edge technology in medical devices. In September Accuray Incorporated (US) entered into a strategic partnership with a leading Indian hospital chain to provide training and support for its CyberKnife systems. This collaboration is significant as it not only expands Accuray's footprint in the Indian market but also enhances the capabilities of local healthcare providers, thereby improving patient access to advanced treatment options. Such partnerships are indicative of a trend where companies leverage local expertise to navigate the complexities of the Indian healthcare system. In August Varian Medical Systems (US) completed the acquisition of a regional competitor, which is expected to enhance its operational capabilities and market share in India. This acquisition aligns with Varian's strategy to consolidate its position in key markets and expand its service offerings. The move is likely to create synergies that improve efficiency and broaden the scope of services available to patients, thereby reinforcing Varian's competitive edge. As of November the gamma knife market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence (AI) into treatment protocols. These trends are reshaping the competitive landscape, as companies increasingly focus on strategic alliances to enhance their technological capabilities. The shift from price-based competition to a focus on innovation and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to deliver advanced, reliable, and efficient treatment solutions. ## Recent News & Developments India's Gamma Knife Market has seen significant developments recently, enhancing its landscape. Zydus Hospitals and Max Healthcare have expanded their services to include advanced stereotactic radiosurgery, improving patient access to cutting-edge treatment options. HCG Oncology and Sunrise Oncology are also enhancing their capabilities, ensuring better treatment of neurological disorders.  June 2023 highlighted a notable collaboration between Narayana Health and Varian Medical Systems to develop advanced cancer treatment protocols incorporating Gamma Knife technology. In terms of mergers and acquisitions, Elekta announced in August 2023 its agreement to acquire a stake in a leading neurosurgery center, enhancing its presence in India's burgeoning market.  The Indian Gamma Knife market is projected to grow substantially, with a focus on increased technological investment. The overall market valuation is on the rise, reflecting the enhanced healthcare infrastructure and the growing need for non-invasive cancer treatment options in India. Fortis Healthcare and Apollo Hospitals are also upgrading their facilities, which contributes to competitive advancements in the sector. The concerted effort by these major players reflects a commitment to embracing innovative technologies in neurosurgical procedures, shaping a more robust healthcare landscape in India. ## Report Scope | MARKET SIZE 2024 | 27.88(USD Million) | | --- | --- | | MARKET SIZE 2025 | 29.76(USD Million) | | MARKET SIZE 2035 | 57.28(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.76% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Elekta AB (SE), Accuray Incorporated (US), Varian Medical Systems (US), Brainlab AG (DE), MediTech (US), Shenzhen Huikang Medical Technology Co., Ltd. (CN), Nico Corporation (US), Stereotactic Radiosurgery (US) | | Segments Covered | Disease Indication, Anatomy | | Key Market Opportunities | Advancements in precision oncology drive growth in the gamma knife market. | | Key Market Dynamics | Rising demand for advanced cancer treatments drives innovation and competition in the gamma knife market. | | Countries Covered | India | ## Frequently Asked Questions **Q: What was the market valuation of the India gamma knife market in 2024?** A: The market valuation of the India gamma knife market was $27.88 Million in 2024. **Q: What is the projected market valuation for the India gamma knife market by 2035?** A: The projected market valuation for the India gamma knife market is $57.28 Million by 2035. **Q: What is the expected CAGR for the India gamma knife market during the forecast period 2025 - 2035?** A: The expected CAGR for the India gamma knife market during the forecast period 2025 - 2035 is 6.76%. **Q: Which disease indications are covered in the India gamma knife market segments?** A: The disease indications include Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, and Others. **Q: What were the market values for Cancer and Brain Metastasis in the India gamma knife market?** A: The market values for Cancer ranged from $10.0 to $20.0 Million, while Brain Metastasis ranged from $5.0 to $10.0 Million. **Q: What anatomical segments are included in the India gamma knife market?** A: The anatomical segments include Head, Neck, and Others. **Q: What were the market values for the Head and Neck anatomical segments in 2024?** A: The market values for the Head segment ranged from $10.0 to $20.0 Million, and for the Neck segment, it ranged from $8.0 to $16.0 Million. **Q: Who are the key players in the India gamma knife market?** A: Key players in the market include Elekta AB, Accuray Incorporated, Varian Medical Systems, Brainlab AG, MediTech, Shenzhen Huikang Medical Technology Co., Ltd., Nico Corporation, and Stereotactic Radiosurgery. **Q: What is the potential growth outlook for the India gamma knife market?** A: The potential growth outlook for the India gamma knife market appears promising, with a projected valuation increase to $57.28 Million by 2035. **Q: How does the India gamma knife market compare to other regions?** A: While specific regional comparisons are not provided, the growth trajectory and key players suggest a competitive landscape in the India gamma knife market. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-gamma-knife-market-52416*